# biolitec

Source: https://onco.cc/companies/biolitec/  
OnCo record `biolitec` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

biolitec is a German medical laser company that holds the EU authorisation for temoporfin (Foscan), a photosensitiser for palliative photodynamic therapy of advanced head and neck cancer.

## Summary

biolitec, based in Jena, is a German medical laser company that holds the EU authorisation for temoporfin, sold as Foscan, a photosensitiser for palliative photodynamic therapy of advanced head and neck cancer. biolitec pharma markets Foscan, authorised in the European Union in 2001 for palliative treatment of advanced head and neck squamous cell carcinoma that has failed prior therapy and is unsuitable for radiotherapy, surgery or systemic chemotherapy, alongside its laser systems. OnCo links it to the temoporfin drug record. Whether photodynamic therapy has a future in head and neck cancer as immunotherapy changes the late-line options is the open question. Temoporfin has its own page.

## Fields

- Kind: Company
- Last checked: 2026-09-10
- HQ: Jena
- Type: devices
- Website: https://www.biolitec.com

## Sources

- Official website: https://www.biolitec.com

## Connected records

- drugs: [Temoporfin](https://onco.cc/drugs/temoporfin/)
- roadmaps: [Devices and physical therapies roadmap: heat and light → electric fields and focused sound → drug-releasing implants](https://onco.cc/roadmaps/devices-roadmap/)
- technologies: [Laser interstitial thermal therapy systems (NeuroBlate, Visualase)](https://onco.cc/technologies/litt-systems/), [Photodynamic therapy lasers and light sources](https://onco.cc/technologies/photodynamic-therapy-lasers/)

---
JSON: https://onco.cc/api/v1/entities/biolitec.json